Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Imatinib D8 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Imatinib D8 is a deuterium-labeled Imatinib. Imatinib is an orally bioavailable tyrosine kinases inhibitor that inhibits BCR/ABL, PDGFR, v-Abl, and c-kit kinase activity. |
Synonyms | CGP-57148B D8, STI571 D8 |
Molecular Weight | 501.65 |
Formula | C29H31N7O |
CAS No. | 1092942-82-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Imatinib-d8 1092942-82-9 Others CGP-57148B D8 Imatinib d8 STI571 D8 Imatinib-d-8 Imatinibd8 inhibitor inhibit